Related Experiment Video
Updated: Jun 12, 2026
10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
An epigenetic hypothesis of aging-related cognitive dysfunction.
Marsha R Penner1, Tania L Roth, Carol A Barnes
1Arizona Research Laboratories Division of Neural Systems, Memory and Aging and Evelyn F. McKnight Brain Institute, University of Arizona Tucson, AZ, USA.
Frontiers in Aging Neuroscience
|June 17, 2010
Summary
Epigenetic mechanisms, such as DNA modifications, may drive age-related memory decline by altering gene expression and brain plasticity. Understanding these epigenetic changes is key to addressing cognitive dysfunction in aging.
Area of Science:
- Neuroscience
- Epigenetics
- Aging Research
Background:
- Aging is associated with memory decline, particularly in declarative/episodic and working memory.
- These memory deficits are linked to reduced brain plasticity in the hippocampus and prefrontal cortex.
- Aberrant gene transcription underlies age-related memory impairments, but the molecular drivers are unclear.
Purpose of the Study:
- To review the role of epigenetic mechanisms in aging-related disruptions of synaptic plasticity and memory.
- To present a hypothesis that dysregulation of epigenetic control drives cognitive dysfunction during aging.
- To discuss current knowledge and future research directions in this field.
Main Methods:
- Review of existing literature on epigenetics, aging, synaptic plasticity, and memory.
- Focus on covalent DNA modifications and nuclear protein post-translational modifications.
- Analysis of studies linking epigenetic alterations to age-related cognitive changes.
Main Results:
- Epigenetic mechanisms, including DNA methylation and histone modifications, can alter chromatin structure and gene expression patterns.
- Dysregulation of these epigenetic mechanisms may lead to aberrant gene transcription in the aging brain.
- Evidence suggests a link between epigenetic alterations and impaired synaptic plasticity and memory formation during aging.
Conclusions:
- Epigenetic dysregulation is a potential driver of age-related cognitive decline and memory deficits.
- Aberrant epigenetic "marks" may underlie the observed changes in gene expression and brain plasticity.
- Further experimental research is needed to elucidate the precise mechanisms and therapeutic potential of targeting epigenetic pathways in aging.
Related Concept Videos
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...